At ARVO 2025, in Salt Lake City, Utah, Dilsher Dhoot, MD, FASRS, and Mark Barakat, MD, talked about the PHOTON trial, 8 mg ...

The rate of AEs among pediatric patients with presumed TB disease was increased for those who received higher vs lower doses of WHO-recommended first-line treatment.

Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data show infant respiratory syncytial virus (RSV) hospitalizat ...

Trial is evaluating VIPER-101, a novel, gene edited, autologous dual-population CAR-T therapy in patients with T-cell ...

Big Tech players will collectively spend over $300 billion on AI-focused infrastructure this year to support the growing ...

"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed.

Despite promising adherence and persistence data, tirzepatide dose escalation was slower in the real-world than clinical trials in patients with obesity without T2D. Tirzepatide dose escalation is ...

To date, 13 patients have received at least one dose of TTX-MC138 at 4 separate ... results and results from TransCode's Phase 0 clinical trial. Specifically, the preliminary PK data follow ...

Please refer to the flow chart (Figure 1). The mean age of intervention participants ... extract type and valerian dose. All previous trials recruited patients with insomnia or healthy volunteers ...